Chest
-
Pleural CasesSESSION TYPE: Case ReportsPRESENTED ON: Sunday, March 23, 2014 at 09:00 AM - 10:00 AMPURPOSE: Posterior mediastinal hemangioma is a very rare tumor. We present a 50-years-old woman admitted to our hospital because of dyspnea and chest pain. A chest x-ray showed a shadow in the aortic arch and a unilateral massive pleural effusion. Serous fluid was aspirate via thoracocentesis, but no malignancy was detected on cytological examination. During the diagnosis process she requires several thoracocentesis to relive the symptoms. CTscan revealed a hypodense and hypervascular circular mass approximately 6 cm in diameter with well defined margins in the posterior mediastinum. Video-assisted thoracoscopic surgery was performed with a total resection of the lesion. The tumor was diagnosed as mediastinal capillary hemangioma with hyaline regression. The pleural effusion was attributed to the capillary mass and no relapsing was shown in further controls. ⋯ The following authors have nothing to disclose: Lucas HOYOS MEJIA, Daniel Valdivia, Jose Manuel Naranjo, Manuel Valle, Lidia Macias, Andres VarelaNo Product/Research Disclosure Information.
-
Pleural CasesSESSION TYPE: Case ReportsPRESENTED ON: Sunday, March 23, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: Neurofibromatosis is an autosomal dominant syndrome. Lateral thoracic meningocele (LTM) is rare but is known to be associated with neurofibromatosis type 1 upto 68.8%1 of times. Here we present an unusual case of pleural drain placement in LTM which mimicked a loculated pleural effusion. ⋯ Large LTM may look like loculated pleural effusion on imaging. In patients with neurofibromatosis, LTM should be considered in the differentials of loculated pleural effusion.Reference #1: de Andrade e al. Giant intrthoracic meningoceles associated with cutaneous neurofibromatosis type I. Arq Neuropsiquiatr. 2003 Sep;61(3A):677-81. Epub 2003 Sep 16Reference #2: M. Kubota, N. Saeki, A. Yamaura. Lateral thoracic meningocele presenting as a retromediastinal mass. Br. J Neurosurgery Dec;16(6):607-8DISCLOSURE: The following authors have nothing to disclose: Naveed Sheikh, Dipaben Modi, Micheal McCormmackNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Some important indications for use of hyperbaric oxygen therapy include treatment of diabetic ulcers, air embolism, carbon monoxide poisoning, and gas gangrene. It is usually well tolerated with very few side effects. We describe a case of acute pulmonary edema precipitated by hyperbaric oxygen treatment. ⋯ The following authors have nothing to disclose: Manveen Dassan, Vishesh Paul, Sameer Chadha, Nidhi Aggarwal, Yizhak Kupfer, Sidney TesslerNo Product/Research Disclosure Information.
-
Pulmonary Vascular Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: 9th edition ACCP guidelines recommended against treating most patients with submassive pulmonary embolism (SPE) with systemic thrombolytics. We report a successful case of delayed use of recombinant tissue plasminogen activator (rtPA) for SPE causing refractory hypoxemia in a patient with a history of spontaneous subdural hemorrhage. ⋯ This case highlights that delayed use of rtPA should be considered in patients with SPE and refractory hypoxemia. History of spontaneous intracranial hemorrhage need not be an automatic absolute contraindication to rtPA use.Reference #1: Konstantinides S, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347(15):1143-1150Reference #2: Stein PD, et al. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Ann Intern Med 1994;121:313-317DISCLOSURE: The following authors have nothing to disclose: Anita Rajagopal, Gabriel BossletNo Product/Research Disclosure Information.